There are 2789 resources available
991P - Treatment-related adverse events (TRAEs) occurring during dostarlimab therapy in the GARNET study
Presenter: Thierry André
Session: ePoster Display
992P - Pan-cancer T-cell priming transcriptomic markers reveals interpatient immunomic heterogeneity independent of histologic type
Presenter: Hirotakka Miyashita
Session: ePoster Display
993P - Glycolytic tumor burden on pretreatment 18F-FDG PET/CT correlates with response and survival in metastatic NSCLC undergoing immune checkpoint inhibitors
Presenter: Saulo Silva
Session: ePoster Display
994P - PCR-based analysis of PD-L1 RNA expression in lung cancer: Comparison with commonly utilized immunohistochemical assays
Presenter: Evgeny Imyanitov
Session: ePoster Display
995P - A pan-cancer analysis of KMT2D as a potential biomarker for immune checkpoint therapy
Presenter: Xiaoqian Guan
Session: ePoster Display
996P - An immune-metabolic signature correlates with immune-suppressive patterns and with outcome, across tumor types
Presenter: Leire Pedrosa
Session: ePoster Display
997P - STK11 and KEAP1 mutational status and their impact in survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: Meta-analyses of clinical trials and cohort studies
Presenter: Gilberto De Castro Jr.
Session: ePoster Display
998P - Investigating the potential relationship between KRAS mutations and immunotherapeutic biomarkers in lung cancer (LC)
Presenter: Zhengbo Song
Session: ePoster Display
999P - NPC patients with post-RT EBV clearance show a higher frequency of peripheral CD8 T-cells expressing chemo-attractant receptors at baseline and during radiation therapy
Presenter: Shweta Mahajan
Session: ePoster Display
1000P - Screening cancer immunotherapeutic agents using high content imaging and analysis of immune-competent 3D InSight tumor models
Presenter: Francesca Chiovaro
Session: ePoster Display
Resources:
Abstract